070 Hemi-cord infarction following vertebral artery dissection in a patient with congenital hypoplastic vertebral artery: A case report

Abstract

Predictive modeling estimated that a 25% reduction in pNfLc, similar to that observed with ozanimod 0.92 mg, predicts an ARR (standard error [SE]) of 0.18-0.23 (0.4), whereas a 13% reduction, similar to IFN, predicts an ARR (SE) of 0.29-0.37 (0.04). Conclusion Our findings support pNfL-c as a biomarker for relapsing MS disease activity. Ozanimod caused greater dosedependent reductions in pNfL-c and ARR than IFN.